Apollo Endosurgery has announced the appointment of Jeannette Bankes to its Board of Directors, bringing the number of board members to eight. Bankes is the President and General Manager of the Global Surgical Franchise at Alcon, a worldwide developer, manufacturer and marketer of eye care medical devices and ophthalmic products.
“Jeannette Bankes is a seasoned healthcare executive and board member known for applying her tremendous insight, experience and passion for technology to optimize product development and worldwide commercialization,” said Chas McKhann, President and CEO of Apollo Endosurgery. “Known throughout the healthcare industry as a thoughtful and practiced leader, Jeannette has led the development and adoption of technologies designed to combat some of healthcare’s most urgent and complex challenges. Her voice and vision will be a tremendous value in helping guide Apollo as we continue to develop and bring to market less invasive devices to advance therapeutic endoscopy.”
Ms. Bankes brings 30 years of experience in the medical device and pharmaceutical industries to her role on the Apollo Endosurgery Board of Directors. She is a proven industry executive, board advisor and product development expert who has held leadership positions in multinational, billion-dollar healthcare companies, Alcon, Boston Scientific, and Merck & Co. As President and General Manager of Alcon’s Global Surgical Franchise, she oversees a diverse, global product portfolio with approximately $5 billion in annual sales. At Boston Scientific, Ms. Bankes’ most recent role was General Manager, Urology & Pelvic Health. During her 15-year tenure at Boston Scientific, Ms. Bankes served as Vice President of Clinical & Regulatory Affairs. Ms. Bankes began her career with Merck & Co., where she held diverse roles of increasing responsibility in sales, marketing, clinical and biological manufacturing. Ms. Bankes holds a B.S. in Biochemistry and Medical Technology from Kutztown University.
“We are pleased to welcome Jeannette to the Apollo Board of Directors,” said John Barr, Chairman of the Board. “Her broad, global experience in R&D, clinical testing, product registration and new product commercialization will provide the Apollo Endosurgery board with valuable perspectives. We are glad to have her join us to help guide Apollo into the future of transforming care delivery.”
“I’m delighted to be joining the Apollo board at this exciting and critical time for the company,” said Bankes. “I look forward to helping the Apollo team further its mission to deliver innovative, cost effective minimally invasive therapeutic GI and bariatric products and procedures to improve patient care.”
Source: Apollo Endosurgery.